Skip to main content

Table 2 Inflammatory markers in the two study groups

From: Could early infusion of fish-oil-based lipid emulsion affect the need for intensive care in moderately diseased COVID-19 patients? A randomized clinical trial

Variables

Group C (n = 30)

Group L (n = 30)

P-value

NLR

 Admission

5.25 (3.30–8.40)

5.60 (3.60–9.00)

0.564

 2nd day

6.35 (3.70–8.30)

6.05 (4.40–8.70)

0.813

 5th day

6.75 (5.20–8.40)

5.85 (8.40–6.80)

0.130

 7th day

9.65 (8.30–10.90)

6.10 (3.90–7.20)

 < 0.001*

Serum ferritin ng/ml

 Admission

200.50 (130.00–320.00)

264.50 (128.00–322.00)

0.712

 2nd day

231.00 (180.00–322.00)

292.50 (190.00–331.00)

0.679

 5th day

289.00 (193.00–357.00)

276.50 (220.00–329.00)

0.767

 7th day

335.50 (202.00–421.00)

285.50 (221.00–352.00)

0.344

D-dimer mcg/ml

 Admission

1.35 (0.80–2.20)

1.15 (0.80–2.00)

0.784

 2nd day

1.50 (1.00–2.40)

1.35 (0.90–1.90)

0.424

 5th day

1.90 (1.20–2.50)

1.30 (1.10–2.00)

0.058

 7th day

2.05 (1.10–3.50)

1.20 (0.90–2.10)

0.087

Serum lactate mmol/L

 Admission

1.30 (0.90–2.00)

1.20 (0.80–2.00)

0.568

 2nd day

1.20 (1.00–1.60)

1.10 (1.00–1.70)

0.242

 5th day

1.35 (1.10–1.90)

1.20 (1.00–2.00)

0.509

 7th day

1.50 (1.10–2.40)

1.10 (0.90–1.80)

0.073

CRP mg/dl

 Admission

15.50 (13.00–24.00)

17.50 (12.00–25.00)

0.871

 2nd day

20.50 (15.00–26.00)

18.00 (14.00–24.00)

0.549

 5th day

22.00 (13.00–32.00)

18.00 (13.00–23.00)

0.131

 7th day

21.50 (15.00–44.00)

17.50 (13.00–22.00)

0.110

IL-6 level pg/ml

 Admission

7.13 ± 2.75

6.91 ± 2.99

0.764

 7th day

7.80 (6.30–10.70)

7.40 (6.00–8.60)

0.297

  1. Data are presented as median and IQ (interquartile range) and mean ± SD
  2. NLR Neutrophil/lymphocyte ratio, CRP C-reactive protein
  3. Group C (standard enteral nutrition) and Group L (fish-oil-based intravenous lipid emulsion)
  4. *P < 0.05 is considered statistically significant